VFO
GILD icon

Virtus Family Office’s Gilead Sciences GILD Stock Holding History

Virtus Family Office’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$772K Hold
6,114
– – 0.61% 45
2026
Q1 		$852K Sell
6,114
-720
-11% -$101K 0.73% 42
2025
Q4 		$839K Buy
+6,834
New +$831K 0.72% 40
2024
Q4 		– Sell
-27,183
Closed -$2.28M – 43
2024
Q3 		$2.28M Sell
27,183
-232
-0.8% -$17.7K 3.01% 11
2024
Q2 		$1.88M Buy
27,415
+5,439
+25% +$363K 2.56% 14
2024
Q1 		$1.61M Hold
21,976
– – 2.57% 18
2023
Q4 		$1.78M Buy
21,976
+856
+4% +$66.6K 2.98% 17
2023
Q3 		$1.58M Buy
21,120
+2,929
+16% +$225K 2.87% 14
2023
Q2 		$1.4M Buy
18,191
+2,169
+14% +$173K 2.6% 16
2023
Q1 		$1.33M Hold
16,022
– – 2.62% 14
2022
Q4 		$1.38M Buy
16,022
+830
+5% +$65.7K 3.07% 10
2022
Q3 		$937K Buy
+15,192
New +$958K 2.39% 13

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Virtus Family Office's GILD Position: Q2 2026 in Review

Virtus Family Office held its Gilead Sciences (GILD) position steady in Q2 2026 at 6,114 shares worth $772K. The position accounts for 0.61% of the portfolio, ranked #45.

Virtus Family Office first reported a position in GILD in Q3 2022 and has held it in 12 quarters since. The position peaked at $2.28M in Q3 2024. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Virtus Family Office held 6,114 shares of Gilead Sciences worth $772K as of Q2 2026.
  • Virtus Family Office left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.61% of Virtus Family Office's portfolio in Q2 2026, its #45 holding.
  • Virtus Family Office first reported a position in Gilead Sciences in Q3 2022 and has held it in 12 quarters since.
  • Virtus Family Office's Gilead Sciences position peaked at $2.28M in Q3 2024.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Virtus Family Office's 13F filing for Q2 2026, filed 4 Aug 2026.